CRV — Craven House Capital Balance Sheet
0.000.00%
- $0.68m
- $0.65m
Annual balance sheet for Craven House Capital, fiscal year end - May 31st, USD millions except per share, conversion factor applied.
2020 May 31st | 2021 May 31st | 2022 May 31st | 2023 May 31st | 2024 May 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Cash and Short Term Investments | 0.006 | 0.005 | 0.001 | 0.004 | 0.002 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.046 | 0.038 | — | — | — |
Prepaid Expenses | |||||
Total Current Assets | 0.052 | 0.043 | 0.044 | 0.042 | 0.031 |
Long Term Investments | |||||
Total Assets | 8.05 | 6.44 | 6.44 | 1.18 | 0.546 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Current Liabilities | 0.254 | 0.087 | 0.076 | 0.109 | 0.241 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 0.254 | 1.08 | 1.31 | 1.56 | 1.82 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 7.8 | 5.37 | 5.13 | -0.384 | -1.28 |
Total Liabilities & Shareholders' Equity | 8.05 | 6.44 | 6.44 | 1.18 | 0.546 |
Total Common Shares Outstanding |